Journal of Biological Chemistry · 2004 · 94 citations · 28 references
Life SciencesImmunologyMolecular BiologyCell SignalingInnate ImmunitySignal TransductionInflammatory Bowel DiseaseInflammatory Cell SignalingInflammatory SignalingInnate Immune Signaling PathwaysNod-like ReceptorsDominant Negative EffectsLeucine-rich Repeat DomainsMitogen-activated Protein Kinase KinaseNf-κb SignalingNod2 SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B InhibitionNuclear Factor Kappa B Signaling
Mutations in the leucine-rich repeat (LRR) domain of Nod2 have been implicated in the pathogenesis of Crohn's disease, yet the function of Nod2 and regulation of the Nod2 pathway remain unclear. In this study, we determined that mitogen-activated protein kinase kinase transforming growth factor (TGF)-β-activated kinase 1 (TAK1) interacts with Nod2 and is required for Nod2-mediated NF-κB activation. The dominant negative form of TAK1 abolished muramyl dipeptide-induced NF-κB activation in Nod2-expressing cells. Nod2, acting in a reciprocal manner, inhibited TAK1-induced NF-κB activation in RICK-deficient embryonic fibroblasts. Nod2 appears to interact with TAK1 through its LRR region to exert its inhibitory effect on TAK1-induced NF-κB activation. Further, wild-type LRR more effectively suppressed NF-κB activation induced by TAK1 than LRR with a 3020insC mutation. Considered together, these findings demonstrate a critical role for TAK1 in Nod2-mediated innate immune responses and reveal a novel function for Nod2 in the regulation of the TAK1 signaling pathway. Mutations in the leucine-rich repeat (LRR) domain of Nod2 have been implicated in the pathogenesis of Crohn's disease, yet the function of Nod2 and regulation of the Nod2 pathway remain unclear. In this study, we determined that mitogen-activated protein kinase kinase transforming growth factor (TGF)-β-activated kinase 1 (TAK1) interacts with Nod2 and is required for Nod2-mediated NF-κB activation. The dominant negative form of TAK1 abolished muramyl dipeptide-induced NF-κB activation in Nod2-expressing cells. Nod2, acting in a reciprocal manner, inhibited TAK1-induced NF-κB activation in RICK-deficient embryonic fibroblasts. Nod2 appears to interact with TAK1 through its LRR region to exert its inhibitory effect on TAK1-induced NF-κB activation. Further, wild-type LRR more effectively suppressed NF-κB activation induced by TAK1 than LRR with a 3020insC mutation. Considered together, these findings demonstrate a critical role for TAK1 in Nod2-mediated innate immune responses and reveal a novel function for Nod2 in the regulation of the TAK1 signaling pathway.
28
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Jean‐Pierre Hugot, Mathias Chamaillard, Habib Zouali et al. · Nature · 2001 · 5.6K citations
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Yasunori Ogura, Denise K. Bonen, Naohiro Inohara et al. · Nature · 2001 · 5K citations · Full text
Patrick A. Baeuerle, David Baltimore · Cell · 1996 · 3K citations · Full text
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Chen Wang, Li Deng, Mei Hong et al. · Nature · 2001 · 2.1K citations